ID19254A - REPLACEMENT DURIVATES, MAKING PROCESS, USAGE AND COMPOSITION OF ITS - Google Patents

REPLACEMENT DURIVATES, MAKING PROCESS, USAGE AND COMPOSITION OF ITS

Info

Publication number
ID19254A
ID19254A IDP973919A ID973919A ID19254A ID 19254 A ID19254 A ID 19254A ID P973919 A IDP973919 A ID P973919A ID 973919 A ID973919 A ID 973919A ID 19254 A ID19254 A ID 19254A
Authority
ID
Indonesia
Prior art keywords
durivates
usage
replacement
composition
making process
Prior art date
Application number
IDP973919A
Other languages
Indonesian (id)
Inventor
Anuschirwan Dr Peyman
Jochen Dr Knolle
Volkmar Dr Wehner
Gerhard Dr Breipohl
Jean-Francois Dr Gourvest
Denis Dr Carniato
Thomas Richard Dr Gadek
Original Assignee
Hoechst Ag
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Genentech Inc filed Critical Hoechst Ag
Publication of ID19254A publication Critical patent/ID19254A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDP973919A 1996-12-20 1997-12-18 REPLACEMENT DURIVATES, MAKING PROCESS, USAGE AND COMPOSITION OF ITS ID19254A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19653646A DE19653646A1 (en) 1996-12-20 1996-12-20 Substituted purine derivatives, processes for their preparation, agents containing them and their use

Publications (1)

Publication Number Publication Date
ID19254A true ID19254A (en) 1998-06-28

Family

ID=7815761

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP973919A ID19254A (en) 1996-12-20 1997-12-18 REPLACEMENT DURIVATES, MAKING PROCESS, USAGE AND COMPOSITION OF ITS

Country Status (21)

Country Link
EP (1) EP0853084B1 (en)
JP (1) JP4620190B2 (en)
KR (1) KR19980064655A (en)
CN (2) CN1101816C (en)
AR (1) AR010700A1 (en)
AT (1) ATE404562T1 (en)
AU (1) AU728865B2 (en)
BR (1) BR9706387A (en)
CA (1) CA2225366C (en)
CZ (1) CZ294437B6 (en)
DE (2) DE19653646A1 (en)
HU (1) HUP9702507A3 (en)
ID (1) ID19254A (en)
IL (1) IL122642A0 (en)
NO (1) NO314583B1 (en)
NZ (1) NZ329431A (en)
PL (1) PL323969A1 (en)
RU (1) RU2228335C2 (en)
TR (1) TR199701647A3 (en)
TW (1) TW523515B (en)
ZA (1) ZA9711317B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1140511C (en) 1998-04-09 2004-03-03 明治制果株式会社 Aminopiperidine derivatives as integrin αvβ3 antagonists
AU2592600A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
UA71945C2 (en) 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
JP3270834B2 (en) 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク Heteroaromatic bicyclic derivatives useful as anticancer agents
EP1065208A1 (en) * 1999-07-02 2001-01-03 Aventis Pharma Deutschland GmbH Substituted purine derivatives as inhibitors of cell adhesion
EP1065207A1 (en) 1999-07-02 2001-01-03 Aventis Pharma Deutschland GmbH Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
WO2001010844A1 (en) 1999-08-05 2001-02-15 Meiji Seika Kaisha, Ltd. φ-AMINO-α-HYDROXYCARBOXYLIC ACID DERIVATIVES HAVING INTEGRIN αvβ3 ANTAGONISM
EP1176145A1 (en) * 2000-07-28 2002-01-30 Aventis Pharma Deutschland GmbH Novel guanidino derivatives as inhibitors of cell adhesion
DE10042655A1 (en) * 2000-08-31 2002-03-14 Aventis Pharma Gmbh Process for the preparation of inhibitors of cell adhesion
KR100438820B1 (en) * 2001-03-05 2004-07-05 삼성코닝 주식회사 Method for manufacturing compound semiconductor substrate of III-V group
JP4660067B2 (en) 2001-04-24 2011-03-30 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Combination therapy using an anti-angiogenic agent and TNFα
FR2847254B1 (en) 2002-11-19 2005-01-28 Aventis Pharma Sa NOVEL VITRONECTIN RECEPTOR ANTAGONIST DERIVATIVES, PROCESS FOR PREPARING THEM, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS REFLECTING THEM
FR2870541B1 (en) * 2004-05-18 2006-07-14 Proskelia Sas ANTIGONISTIC PYRIMIDINE DERIVATIVES OF VITRONECTIN RECEPTOR
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
BRPI0706540A2 (en) 2006-01-18 2011-03-29 Merck Patent Gmbh specific therapy using integrin ligands to treat cancer
EP2441464B1 (en) 2007-01-18 2014-04-09 Merck Patent GmbH Integrin ligands for use in treating colon cancer
BRPI0818437B8 (en) * 2007-10-11 2021-05-25 Daiichi Sankyo Co Ltd antibody or antibody functional fragment, pharmaceutical composition, use of at least one of the antibodies or antibody functional fragments, and hybridoma
NZ586129A (en) * 2007-11-14 2012-06-29 Myrexis Inc Therapeutic compounds and their use in treating diseases and disorders
MX343049B (en) 2009-04-09 2016-10-21 Daiichi Sankyo Co Ltd ANTI-Siglec-15 ANTIBODY.
CN102448497A (en) 2009-05-25 2012-05-09 默克专利有限公司 Continuous administration of integrin ligands for treating cancer
MX2013003828A (en) 2010-10-05 2013-06-28 Daiichi Sankyo Co Ltd Antibody targeting osteoclast-related protein siglec-15.
MX2014011828A (en) 2012-03-30 2014-12-10 Daiichi Sankyo Co Ltd Anti-siglec15 antibody with modified cdr.
CN103665043B (en) 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 A kind of tenofovir prodrug and its application in medicine
ES2864079T3 (en) 2014-05-30 2021-10-13 Pfizer Carbonitrile derivatives as selective androgen receptor modulators
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators
US20240247001A1 (en) 2022-12-16 2024-07-25 Astrazeneca Ab 2,6,9-trisubstituted purines

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4730696Y1 (en) * 1966-12-10 1972-09-13
SU896875A1 (en) * 1979-11-27 1995-01-09 Ленинградский химико-фармацевтический институт Method of obtaining 9-bromadenine
JPS6396663A (en) * 1986-10-13 1988-04-27 Mita Ind Co Ltd Electrostatic charge image developing toner
JPS6396553A (en) * 1986-10-14 1988-04-27 Sekisui Chem Co Ltd Packing material
DE4129603A1 (en) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS
MX9207334A (en) * 1991-12-18 1993-08-01 Glaxo Inc NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM
FR2700337B1 (en) * 1993-01-11 1995-04-14 Lafon Labor Imidazopyridine-2-one derivatives, their preparation process and their use in therapy.
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
DE4405378A1 (en) * 1994-02-19 1995-08-24 Merck Patent Gmbh Adhesion receptor antagonists
US5554746A (en) * 1994-05-16 1996-09-10 Isis Pharmaceuticals, Inc. Lactam nucleic acids
US5929046A (en) * 1994-06-08 1999-07-27 Cancer Research Campaign Technology Limited Pyrimidine and purine derivatives and their use in treating tumour cells
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
NZ290008A (en) * 1994-06-29 1998-08-26 Smithkline Beecham Corp Vitronectin receptor antagonists, comprising a fibrinogen antagonist analogue linked to a heterocycle
US5525606A (en) * 1994-08-01 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
WO1996020212A2 (en) * 1994-12-28 1996-07-04 Buchardt, Dorte Peptide nucleic acid incorporating a chiral backbone
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
DE69632324T2 (en) * 1995-06-07 2005-06-16 PerSeptive Biosystems, Inc., Framingham PNA-DNA CHIMESES AND PNA SYNTHESES FOR THEIR PREPARATION
JP2000507552A (en) * 1996-03-26 2000-06-20 デュポン ファーマシューティカルズ カンパニー Aryloxy and arylthio fused pyridines, aryloxy and arylthio fused pyrimidines and derivatives thereof
JPH1025294A (en) * 1996-03-26 1998-01-27 Akira Matsuda Fused heterocyclic derivative, method for producing the same, and therapeutic agent for malignant tumor containing the same
GB9613021D0 (en) * 1996-06-21 1996-08-28 Pharmacia Spa Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
EP0960121B1 (en) * 1996-07-24 2005-11-30 BUCHARDT, Dorte Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2

Also Published As

Publication number Publication date
JP4620190B2 (en) 2011-01-26
EP0853084A3 (en) 1998-09-09
NO314583B1 (en) 2003-04-14
HK1012190A1 (en) 1999-07-30
CN1495184A (en) 2004-05-12
ZA9711317B (en) 1998-06-22
CN1101816C (en) 2003-02-19
CA2225366A1 (en) 1998-06-20
DE59712958D1 (en) 2008-09-25
HU9702507D0 (en) 1998-03-02
BR9706387A (en) 2000-03-14
CZ294437B6 (en) 2005-01-12
DE19653646A1 (en) 1998-06-25
PL323969A1 (en) 1998-06-22
TW523515B (en) 2003-03-11
RU2228335C2 (en) 2004-05-10
MX9710277A (en) 1998-10-31
EP0853084B1 (en) 2008-08-13
AU728865B2 (en) 2001-01-18
NZ329431A (en) 2000-01-28
AR010700A1 (en) 2000-06-28
CZ411497A3 (en) 1998-07-15
ATE404562T1 (en) 2008-08-15
IL122642A0 (en) 1998-08-16
NO975977L (en) 1998-06-22
CN1193623A (en) 1998-09-23
NO975977D0 (en) 1997-12-19
TR199701647A2 (en) 1998-07-21
CA2225366C (en) 2006-10-10
JPH10182645A (en) 1998-07-07
KR19980064655A (en) 1998-10-07
HUP9702507A3 (en) 1999-12-28
TR199701647A3 (en) 1998-07-21
HUP9702507A2 (en) 1999-05-28
AU4846697A (en) 1998-06-25
EP0853084A2 (en) 1998-07-15

Similar Documents

Publication Publication Date Title
ID19254A (en) REPLACEMENT DURIVATES, MAKING PROCESS, USAGE AND COMPOSITION OF ITS
PL331854A1 (en) Phosphinamides as inhibitors of metaloprotease matrix
ID17271A (en) PROCESS FOR CHANGE OF ETHYLBENZENA
ID24255A (en) PROCESS OF MAKING WITH SHARP AROMA
IL136086A0 (en) New composition of matter
ID17524A (en) PROCESS OF UTILIZATION OF VAPUM TEKANA ABSORPTION
ZA984127B (en) New composition of matter
DE69634562D1 (en) HIGH-PURPOSE COMPOSITION FOR OVEN PARTS
HU9602086D0 (en) Glass composition
ID22641A (en) PROCESS OF MAKING E-KAPROLAKTAM
ID16457A (en) TERMINAL ALDEHIDAL MAKING PROCESS
ID26902A (en) PROCESS AND RADAS FOR MAKING MELAMINA
ID18521A (en) THE OLEFIN-OLEFIN PROCESS
HU9602087D0 (en) Glass composition
PL333112A1 (en) Substitute derivatives of 4-biphenyl-4-hydroxybutyric acid as inhibitors of matrix metaloproteases
ID16994A (en) PROCESS UNIT
PT1021444E (en) DERIVATIVES 3-CARBOXAMIDE OF 5H-PYRROLO ²2,1-C | ¬1,4 | -BENZODIAZEPINAS
ID26660A (en) PROCESS OF MAKING BUTANA-1,4-DIOL, GAMMA-BUTIROLAKTON AND TETRAHIDROFURAN
ID22222A (en) PROCESS OF MAKING SUBSTITUTED TIAZOLIDINADION
ID23155A (en) EPROSARTANT MAKING PROCESS
ID22456A (en) PROCESS OF MAKING DIESTER-DIESTER 2,3,5-TRIMETHYL HYDROXININON
HUP9600148A3 (en) Glass composition
ID22478A (en) DETERGENT COMPOSITION PRODUCTION PROCESS
ID25511A (en) HYDROGENATION PROCESS DINITRIL
ID23181A (en) EPROSARTANT MAKING PROCESS